[ Price : $8.95]
The CDER Office of Pharmaceutical Quality 2022 annual reports touts how alternative review techniques aided regulatory decision-ma...[ Price : $8.95]
CBER director Peter Marks tells a conference he would like to see a Project Orbis-style multi-national effort to spur the developm...[ Price : $8.95]
The Los Angeles Times says FDA is learning how to use social media to combat those promoting disinformation and denying science.[ Price : $8.95]
The U.S. Department of Justice says over $2.2 billion was collected in settlements and judgments under the False Claims Act during...[ Price : $8.95]
A new journal article by CBER reviewers finds uncertainty about assessment of the safety profile as a top discussion item at 24 ad...[ Price : $8.95]
FDA clears a Hyperfine 510(k) for its upgraded Swoop AI-powered software for use with the Swoop Portable MR Imaging System.[ Price : $8.95]
FDA accepts for review an Ocuphire Pharma NDA for Nyxol (phentolamine ophthalmic solution 0.75%) for treating pharmacologically-in...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled FDA Advisory Committees; Information Co...